Psoriasis vulgaris associated with acne vulgaris: differential effects of biologicals?
Colsman
Andreas
A
Sticherling
Michael
M
D000152:Acne Vulgaris / Q000188:drug therapy*; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha; C472181:efalizumab